Business Context and Reporting Period
This Form 8-K was filed by Oragenics, Inc. on January 23, 2012. The report details the entry into a material definitive agreement involving the amendment of the Company's existing unsecured revolving line of credit with the Koski Family Limited Partnership (KFLP), an accredited investor and the Company's largest shareholder.
Key Financial Metrics
- Credit Facility Limit: Increased from $7,500,000 to $8,250,000.
- Recent Drawdown: $750,000 borrowed on January 23, 2012.
- Total Outstanding Debt: $8,250,000 owed to KFLP.
- Remaining Availability: $0 (fully utilized).
- Interest Rate: LIBOR plus 6.0%.
- Maturity Date: July 30, 2012.
Material Changes
The primary material change is the execution of the Fifth Amendment to the Credit Facility. This amendment increased the borrowing capacity by $750,000. The Company immediately drew down the full amount of the increase. The filing notes a history of five amendments since the original agreement in July 2010, progressively increasing the facility from an initial $2.0 million to the current $8.25 million to support working capital and operational needs.
Outlook, Risks, and Contingencies
The filing does not provide specific forward-looking guidance, revenue projections, or management commentary regarding future business performance. The primary contingency noted is the repayment obligation of the $8,250,000 principal amount due on July 30, 2012. The agreement includes a provision allowing for the automatic conversion of outstanding amounts into Company securities in subsequent offerings and grants KFLP the right to put undrawn amounts to the Company.
Investor Verification Checklist
- Verify the Company's ability to repay the $8,250,000 debt due on July 30, 2012, given the lack of remaining credit availability.
- Review the terms regarding the automatic conversion of debt into equity to assess potential dilution.
- Confirm the relationship and voting power of KFLP as the largest shareholder and sole lender.
- Check for any subsequent filings regarding the Company's cash position or new financing arrangements.